Helius Medical Technologies is trading 7.14% up in pre-market at $2.40, versus the September 4 close of $2.24; no fresh company-specific catalyst has been identified for September 8, 2026.
- Its investor-relations page lists August 27 as the latest update before this session.
- Recent search results mainly reference older Solana-related developments.
- With major U.S. indexes lower, the move may reflect limited liquidity or a delayed reaction to prior news.